NCT07252726 2026-02-09
Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers
Ottawa Hospital Research Institute
Phase 4 Recruiting
Clinical Trials
12 trialsNCT05348876 2026-01-30
A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)
Bayer
Phase 4 Recruiting
NCT04373564 2026-01-22
ODYSSEY
Guerbet
Phase 4 Recruiting
NCT06226129 2025-10-20
Gadopiclenol in Contrast Enhanced MRI of the Prostate
Columbia University
Phase 4 Recruiting
NCT06908694 2025-07-29
GAINPCCONTROL
Hamilton Health Sciences Corporation
Phase 4 Recruiting
NCT07001709 2025-06-03
ENABLE
Deventer Ziekenhuis
Phase 4 Recruiting
NCT05805436 2025-05-30
Preop Laxatives in Robotic Urologic Surgery
University of Iowa
Phase 4 Recruiting
NCT05803941 2025-04-24
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Novartis
Phase 4 Recruiting
NCT06706921 2024-11-27
18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
VA Greater Los Angeles Healthcare System
Phase 4 Recruiting
NCT05629494 2024-10-18
ADAPT-PSA
Albany Medical College
Phase 4 Recruiting
NCT05957822 2024-05-14
Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery
Konkuk University Medical Center
Phase 4 Recruiting
NCT06001619 2023-08-21
PROMED
Turku University Hospital
Phase 4 Recruiting